CRCHD: Cancer Health Disparities Research and Diversity Training Opportunities
Mary Ann S. Van Duyn, PhDCenter to Reduce Cancer Health Disparities
NCI Division of Cancer Biology New Grantee WorkshopMarch 12, 2014
URMs Truly Are Underrepresented in the Cancer Research Workforce
Drew, ASBMB Today, Jan 2010.
Majority Minorities…Changing Face of the U.S.
Why is Diversity Important?
• Broadens the research “lens” to include new viewpoints from those from diverse backgrounds
• Enhances innovation and creativity in cancer research
• Contributes to reducing cancer disparities by more effectively addressing existing disparities within the population
• Promotes fairness in the use of public funds for cancer research
• Consistent with NIH’s Commitment to Excellence: providing support for talented individuals to explore ideas at the highest level of inquiry
Probability of NIH R01 awards by Race and Ethnicity (FY 2000-FY 2006 ) (N =
83,188)
• Coordinates and strengthens the NCI cancer research portfolio in basic, clinical, translational and population-based research to reduce cancer health disparities
• Leads NCI’s efforts in the training of students and investigators from diverse populations in cancer and cancer health disparities (CHD) research
Within CRCHD and Across the NCI Divisions, Offices and
Centers
NCI CRCHD Mission
Center to Reduce Cancer Health Disparities
ResearchCNP Centers
Basic Research in Cancer Health Disparities
Diversity TrainingCURE
Promoting Workforce Diversity in Cancer Research
PACHE
Integration of Research, Training, and Community
National Outreach NetworkG/BMaP
NCCCP/NCORP Liaison
Basic Research – CRCHD/DCB Collaboration
CRCHD
R21/U01
• Understanding Biological Variations• Determining Mechanisms and Pathways• Creating Tailored Diagnostics/Therapies
• All Eligible• Preliminary data is not required• $275K Direct Cost Limit for 2 year project period
http://grants.nih.gov/grants/guide/pa-files/PAR-12-094.html
To support pilot and feasibility studies and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities
Exploratory/Developmental Grant for Basic Cancer Research in Cancer
Health Disparities (R21) PAR-12-094
Basic Cancer Research in Cancer Health Disparities (U01) PAR-12-095
• All Eligible• Preliminary Data Required• $250K Direct Cost Limit per year and not to exceed 5 years
http://grants.nih.gov/grants/guide/pa-files/PAR-12-095.html
To conduct basic, mechanistic research into the biological/genetic causes of cancer health disparities.
R21/U01 Basic Research in Cancer Health Disparities (PAR-12-094/095)
Topics of U01 grants funded in FY 2013• Role of Chemokine Receptors in Prostate Cancer Progression Disparities• Investigations on HPV Variants and Ethnic Disparities in Cervical Cancer• Metabolic Profiles and Racial/Ethnic Disparities in Breast Cancer
Topics of R21 grants funded in FY 2012• Significance of Cancer Stem/Stem-like Cells in African-Americans with Colorectal
Cancer • Viral and Immune Host Response Factors as Biological Bases of Disparity in Liver
Cancer Survival among Asian Americans • Role Of MicroRNAs in Prostate Cancer among African-Americans• Glycation as a Mechanism Promoting Cancer Health Disparity• Significance of Mitochondrial DNA in African-American Prostate Cancer Patients
* 1 Lymphoma, 1 Liver Cancer, 1 Wilms‘ Tumor , 3 Multiple Cancers
Prostate Breast Colorectal Leukemia Cervical Other012345678
Research by Cancer Type (2010-13)
Fund
ed
Provocative Questions RFA
R01 and R21 mechanisms are available for each PQ
PQC – 3: How do variations in tumor-associated immune responses among patients from distinct well-defined populations, such as various racial/ethnic or age groups, contribute to differences in cancer outcomes?
For more information: http://provocativequestions.nci.nih.gov/
Group A
Cancer Prevention and Risk
Group B
Mechanisms of Tumor Develop-ment or
Recurrence
Group C
Tumor Detection, Diagnosis,
and Prognosis
Group D
Cancer Therapy and Outcomes
Group D
Clinical Effectiveness
Diversity Training
Training
CURE
Promoting Workforce Diversity in Cancer Research (R21)
Continuing Umbrella of Research Experiences (CURE)
T R A I N E E S
High School Undergradu
ate
Pre -doctoral
Early Stage
InvestigatorsPostdoctor
al
Increase the size of the talent pool
Emphasize scientific areas of
greatest need
Expand and extend the period of training
HS Undergrad. Predoctoral Postdoctoral Early Stage Investigator
Diversity Supplements
R25TS: Cancer Prevention and
Control Clinical Oncology
Training Grants: K12S
TransitionCareer: K22
NRSA Fellowships: F31
Career Awards:K01 K08 K23
P30 Supplementsfor HS and UG students
NRSA Training Grants:T32S
R
0
1
Continuing Umbrella Research Experiences
R21
Re-Entry Supplements
Research Supplements to Promote Diversity in Health-Related Research (Administrative Supplements
http://grants.nih.gov/grants/guide/pa-files/PA-12-149.html
• Improve the diversity of the research workforce• Students, post doctorates, and eligible investigators
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Administrative Supplement)
http://grants.nih.gov/grants/guide/pa-files/PA-12-150.html
• Individuals with high-potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances
• Support for full-time or part-time research, salary and supplies within the missions of all the program areas of NIH.
Research Supplements to Promote Diversity and Re-Entry
Research Supplements to Promote Diversity in Health-Related Research (Administrative Supplement)
http://grants.nih.gov/grants/guide/pa-files/PA-12-149.html
• Improve the diversity of the research workforce• Students, post doctorates, and eligible investigators
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Administrative Supplement)
http://grants.nih.gov/grants/guide/pa-files/PA-12-150.html
• Individuals with high-potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances
• Support for full-time or part-time research, salary and supplies within the missions of all the program areas of NIH.
Research Supplements to Promote Diversity and Re-Entry
CRCHD DCB DCCPS DCP DCTD CSSI0
50
100
150
200
250
300
350
400
450
500
Supplement Awards by Division/Center (2001-2012)
Series1
Divisions/Centers
Num
ber o
f Aw
ards
CURE – NRSA Fellowships (F31)Ruth L. Kirschstein National Research Service Awards for Individual Pre-doctoral Fellowships • Pre-doctoral (up to 5 years) support for candidates in biomedical, behavioral, or clinical sciences
• Fellowship Requirements – Experienced mentor, enrollment in a
graduate school
• Allowable Costs – Annual stipend for Fellow’s living expenses, tuition & fees, and health insurance
• Submission dates – 4/13, 8/13, 12/13 (Electronic Submission)
http://grants.nih.gov/grants/guide/pa-files/PA-10-109.html
NCI Mentored Research Scientist Development Award to Promote Diversity (K01)
PAR-12-050
BASIC & POPULATION SCIENCE
• Individuals with research or health professional doctorate degree
• 100K Salary/30K R&D; 3-5 years support
• Submission Dates: 2/12, 6/12, 10/12
Mentored Career Development Award (K01)
• Eligibility: Investigators from Diverse Backgrounds• Preliminary Data is not required• $275K Direct Cost limit for 2 year project period
http://grants.nih.gov/grants/guide/pa-files/PAR-12-096.html
To improve the diversity of the research workforce by supporting and recruiting eligible investigators from groups that have been shown to be underrepresented.
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer
Research (R21) PAR-12-096
Geographical Management Program (GMaP)
• Foster team science• Promote cross-training in
emergent areas of science and in basic, clinical, and population-based science• Enhance personalized
career mentoring• Share successful training
and research models • Link ESI from CURE to
available academic job opportunities to build critical mass
Basic Cancer Health Disparities Research (R21 and U01)Dr. Rina Das [email protected]
Community Networks Program CentersDr. Rina Das [email protected]. Liz Perruccio [email protected]. Precilla Belin [email protected]
Diversity Supplements and U54Dr. Alison Lin [email protected]
NRSA (F31 and T32S)Dr. Anil Wali [email protected]
Supplements to the CURE (P30S, R25TS, K12S) Dr. Alison Lin [email protected]
Career Development Awards (K)Dr. John Ojeifo (K01, K08, K23) [email protected]
Exploratory Grant (Diversity R21)Dr. Anil Wali [email protected]
PACHE Program (P20, U54) Dr. Carmen Moten [email protected]
CRCHD General Contact Number: 240-276-6170
Promoting the Mission
http://crchd.cancer.gov
New!
New!